Novocure Ltd Ord Sh (NVCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVCR | AZN | AMGN | GILD | BMY |
| Company | Novocure Ltd Ord Sh | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 12.88 | 200.00 | 377.97 | 148.13 | 61.57 |
| High | 13.55 | 201.99 | 381.74 | 148.84 | 61.95 |
| Low | 12.25 | 197.10 | 372.71 | 145.52 | 60.43 |
| Latest | 13.30 | 201.76 | 377.00 | 147.83 | 61.22 |
| Change | -0.22 | -1.97 | -8.70 | -2.20 | -1.12 |
| % Change | -1.63% | -0.97% | -2.26% | -1.47% | -1.80% |
| Volume | 1,950,000 | 2,733,100 | 2,710,500 | 6,741,600 | 12,425,200 |
| 20-Day Average Volume | 3,330,940 | 2,484,955 | 3,077,185 | 7,869,630 | 14,196,500 |
| Previous Close | 13.52 | 203.73 | 385.70 | 150.03 | 62.34 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.77 | 200.72 | 373.98 | 149.93 | 60.47 |
| 20-Day Raw Stochastic | 61.70% | 62.35% | 72.88% | 38.01% | 77.47% |
| 20-Day Relative Strength | 54.14 | 55.79 | 58.44 | 56.65 | 61.66 |
| Weighted Alpha | -24.42 | +38.21 | +26.29 | +35.63 | +14.58 |
| Today's Opinion | Hold | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Previous Opinion | Hold | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 56% Sell | 88% Buy | 100% Buy | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +13.29% since 02/24/26 | -2.35% since 02/24/26 | -1.53% since 02/24/26 | +0.13% since 02/24/26 | -0.62% since 02/24/26 |
| Low | 11.80 on 02/26/26 | 197.10 on 03/03/26 | 372.71 on 03/03/26 | 143.09 on 02/26/26 | 60.43 on 03/03/26 |
| High | 15.46 on 02/25/26 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 1-Month | |||||
| %Chg | +12.33% since 02/03/26 | +9.46% since 02/03/26 | +11.34% since 02/03/26 | +3.18% since 02/03/26 | +9.34% since 02/03/26 |
| Low | 9.82 on 02/09/26 | 186.32 on 02/04/26 | 342.38 on 02/04/26 | 143.09 on 02/26/26 | 56.43 on 02/04/26 |
| High | 15.46 on 02/25/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +12.62% since 12/03/25 | +11.04% since 12/03/25 | +9.14% since 12/03/25 | +18.26% since 12/03/25 | +20.13% since 12/03/25 |
| Low | 9.82 on 02/09/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.22 on 12/04/25 |
| High | 15.46 on 02/25/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +10.10% since 09/03/25 | +22.86% since 09/03/25 | +32.82% since 09/03/25 | +30.83% since 09/03/25 | +28.88% since 09/03/25 |
| Low | 9.82 on 02/09/26 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 15.46 on 02/25/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,538,495 | 315,966,464 | 207,918,544 | 186,250,400 | 126,953,792 |
| Shares Outstanding, K | 113,794 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 655,350,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -136,230,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 174,350,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -24,500,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.71 | 0.32 | 0.45 | 0.36 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.22 on 02/26/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 04/23/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.73 | 17.76 | 18.28 | 10.14 |